Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of cytisine for smoking cessation: downward titration vs simplified three-times-daily regimen
TCTR20240711001Phase 3Recruiting
- Sponsor
- Thai Health Promotion Foundation
- Start
- Jul 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cytisinicline in nicotine dependence, sponsored by Thai Health Promotion Foundation. Started Jul 2024; status: recruiting.
02
Drugs
cytisinicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on TCTR20240711001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240711001.